| CRISPR Medicine | This is an overview of articles on safety
The FDA recently placed a temporary hold on a clinical trial with TALEN gene-edited CAR T-cells. A patient enrolled in this trial developed...
Just as the summer was creeping in, we hosted our most popular CMN webinar to date. The topic was CRISPR Off-Targets with speakers from academia and a...
Erik Sontheimer, Professor and Vice Chair at the RNA Therapeutics Institute and at the University of Massachusetts Medical School talks to CRISPR...
DECODR's algorithm can quickly — and cheaply — make sense of Sanger sequencing data at a very precise level.
Just 8 years after the development of CRISPR-Cas technology, Vertex Pharmaceuticals and CRISPR Therapeutics share positive clinical data for their ex...
With the Nobel Prize in Chemistry being awarded to the founding mothers of CRISPR - Emmanuelle Charpentier and Jennifer Doudna - genome editing is...
CRISPR is believed to hold the cure for many rare single-gene disorders that are otherwise incurable. Alessia Cavazza’s group at University College...
We have added a new cancer immunotherapy trial by CRISPR Therapeutics to our overview of current clinical trials involving gene editing.
